Business Context and Reporting Period
This Form 8-K reports the results of the 2024 Annual Meeting of Stockholders held by Aquestive Therapeutics, Inc. on June 20, 2024. The filing details the election of directors, executive compensation votes, and the ratification of the independent auditor.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes.
Material Changes and Voting Results
Director Elections (Class III)
Three nominees were elected to serve three-year terms until the 2027 Annual Meeting. All nominees received significant support, though there were notable abstentions.
- Santo J. Costa: 24,888,723 votes for; 680,370 abstaining.
- Julie Krop, M.D.: 21,612,732 votes for; 3,955,911 abstaining.
- Marco Taglietti, M.D.: 24,940,348 votes for; 628,295 abstaining.
There were 26,244,609 broker non-votes for all director nominees.
Executive Compensation
- Advisory Vote on Compensation: Approved with 23,574,514 votes for and 1,566,897 votes against.
- Frequency of Advisory Vote: Approved for a one-year frequency with 24,588,404 votes for and 267,927 abstaining.
Auditor Ratification
KPMG LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2024, with 50,666,378 votes for and 895,258 votes against.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the total number of shares entitled to vote versus the total votes cast to assess shareholder participation rates.
- Review the specific reasons for the high number of abstentions (approx. 3.9 million) for nominee Julie Krop, M.D.
- Confirm the exact term end dates for the newly elected Class III directors in the company's bylaws.
- Check subsequent filings for the full proxy statement to understand the context of the "against" votes on executive compensation.